17 research outputs found
ΠΠ΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΡΡΠ΅ΠΊΡΠΎΡΠ° ΡΠΎ ΡΠ²ΠΎΠΉΡΡΠ²Π°ΠΌΠΈ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΠ Π‘ 19 Π½Π° ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠΈ Π²ΠΎΠ΄ΠΎΡΠΎΠ΄Π° ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΌΠΈΠ΅Π»ΠΎΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·Ρ Π² ΡΠΌΡΠ²Π°Ρ ΠΈΠ· ΠΏΠΎΠ»ΠΎΡΡΠΈ Π½ΠΎΡΠ° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Ρ Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π±ΡΠΎΠ½Ρ ΠΈΡΠΎΠΌ
Twenty eight adults of both genders with chronic bronchitis participated in the open trial studying the influence of the local immune modulating drug IRS 19 with vaccine properties on polymorphonuclear leukocytes number, H202 concentration and myeloperoxidase activity in nasal washes. The polymorphonuclear leukocytes number increased from 4460Β±3960 to 10490Β±10950 cells per ml (p<0.02) after two months of IRS 19 use. This effect accompanied by the myeloperoxidase activity and the H202 concentration increase in 2.6 and 1.4 times, correspondingly (p<0.001). As the "polymorphonuclear leukocytes and myeloperoxidase β H202 β ClΛ " system is the first-line defence against pathogenic microorganisms, the changes mentioned above are likely to be one of the mechanisms enhancing the airways antibacterial immunity in response to the IRS 19 therapy.ΠΠ²Π°Π΄ΡΠ°ΡΡ Π²ΠΎΡΠ΅ΠΌΡ Π²Π·ΡΠΎΡΠ»ΡΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΎΠ±ΠΎΠ΅Π³ΠΎ ΠΏΠΎΠ»Π°, ΡΡΡΠ°Π΄Π°ΡΡΠΈΠ΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π±ΡΠΎΠ½Ρ
ΠΈΡΠΎΠΌ, ΠΏΡΠΈΠ½ΡΠ»ΠΈ ΡΡΠ°ΡΡΠΈΠ΅ Π² ΠΎΡΠΊΡΡΡΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ, ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π½ΠΎΠΌ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠ° ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅ΡΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠΌΠΎΠ΄ΡΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΡΠΎ ΡΠ²ΠΎΠΉΡΡΠ²Π°ΠΌΠΈ Π²Π°ΠΊΡΠΈΠ½Ρ ΠΠ Π‘ 19 Π½Π° ΡΠΈΡΠ»ΠΎ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΠΎΡΠ΄Π΅ΡΠ½ΡΡ
Π»Π΅ΠΉΠΊΠΎΡΠΈΡΠΎΠ² (ΠΠΠ―Π), ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ Π202 ΠΈ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΌΠΈΠ΅Π»ΠΎΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·Ρ (ΠΠΠ) Π² ΡΠΌΡΠ²Π°Ρ
ΠΈΠ· ΠΏΠΎΠ»ΠΎΡΡΠΈ Π½ΠΎΡΠ°. Π§ΠΈΡΠ»ΠΎ ΠΠΠ―Π, Π²ΡΠ΄Π΅Π»ΡΠ²ΡΠΈΡ
ΡΡ ΠΈΠ· ΠΏΠΎΠ»ΠΎΡΡΠΈ Π½ΠΎΡΠ°, ΡΠ²Π΅Π»ΠΈΡΠΈΠ»ΠΎΡΡ ΠΏΠΎΡΠ»Π΅ Π΄Π²ΡΡ
ΠΌΠ΅ΡΡΡΠ΅Π² ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΠ Π‘ 19 Ρ 4460Β±3960 Π΄ΠΎ 10 490Β±10 950 ΠΊΠ»Π΅ΡΠΎΠΊ Π½Π° ΠΌΠ» (Ρ<0,02). ΠΡΠΎΡ ΡΡΡΠ΅ΠΊΡ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»ΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ΠΌ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΠΠ ΠΈ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π202, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ, Π² 2,6 ΠΈ 1,4 ΡΠ°Π·Π° (Ρ<0,001). ΠΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΡΠΈΡΡΠ΅ΠΌΠ° ΠΠΠ―Π ΠΈ ΠΠΠ β Π202 β CIΛ Π½Π°Ρ
ΠΎΠ΄ΠΈΡΡΡ Π½Π° ΠΏΠ΅ΡΠ΅Π΄Π½Π΅ΠΌ ΠΊΡΠ°Π΅ Π·Π°ΡΠΈΡΡ ΠΎΡ ΠΏΡΠΎΠ½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΡΡ
ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠΎΠ², ΠΌΠΎΠΆΠ½ΠΎ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΡ, ΡΡΠΎ ΡΠΏΠΎΠΌΡΠ½ΡΡΡΠ΅ Π²ΡΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠΎΠ³ΡΡ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡ ΡΠΎΠ±ΠΎΠΉ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ², ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡΠΈΡ
ΠΊ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° Π² ΠΎΠ±Π»Π°ΡΡΠΈ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΡΠ΅ΠΉ Π² ΠΎΡΠ²Π΅Ρ Π½Π° Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ ΠΠ Π‘ 19
Measurement of the Tau Lepton Polarisation at LEP2
A first measurement of the average polarisation P_tau of tau leptons produced in e+e- annihilation at energies significantly above the Z resonance is presented. The polarisation is determined from the kinematic spectra of tau hadronic decays. The measured value P_tau = -0.164 +/- 0.125 is consistent with the Standard Model prediction for the mean LEP energy of 197 GeV.A first measurement of the average polarisation PΟ of tau leptons produced in e + e β annihilation at energies significantly above the Z resonance is presented. The polarisation is determined from the kinematic spectra of tau hadronic decays. The measured value PΟ=β0.164Β±0.125 is consistent with the Standard Model prediction for the mean LEP energy of 197 GeV.A first measurement of the average polarisation P_tau of tau leptons produced in e+e- annihilation at energies significantly above the Z resonance is presented. The polarisation is determined from the kinematic spectra of tau hadronic decays. The measured value P_tau = -0.164 +/- 0.125 is consistent with the Standard Model prediction for the mean LEP energy of 197 GeV
Estimation de l'index de pression cheville-bras par laser DΓΆppler chez les patients artΓ©ritiques
Effects of parathyroid hormone and cyclic AMP analogues on the activity of ornithine decarboxylase and expression of the differentiated phenotype of chondrocytes in culture
Diagnostic tools for bacterial infections in travellers: Current and future options
International audienceInternational travel has increased dramatically over the past 50 years, and travel destinations have diversified. Although physicians are more familiar with the panel of aetiological agents responsible for illnesses of returning travellers, thanks to regular epidemiological studies, the spectrum of pathogens potentially encountered in various travel destinations is nevertheless increasing. In addition, the wide array of approaches currently available and addressed in this paper could render the procedures for microbiological analyses increasingly complex. As the time to result is crucial to adequately manage patients, modern approaches have been developed to shorten diagnosis delays. The syndromic approach, which consists of simultaneously testing a wide panel of microorganisms, substantially increases the diagnostic yield with significant time savings, particularly when coupled with point-of-care laboratories. The tools commonly used for this purpose are immunochromatographic tests, mainly targeting bacterial antigens, and multiplex real-time PCR. The emergence of next-generation sequencing technologies, which enable random amplification of genetic material of any microbe present in a clinical specimen, provides further exciting perspectives in the diagnosis of infectious diseases
Dietary supplements and other alternative medicines for erectile dysfunction What do I tell my patients?
Measurement of the Mass and Width of the W Boson in Collisions at = 161 - 209 GeV
A measurement of the W boson mass and width has been performed by the DELPHI collaboration using the data collected during the full LEP2 programme (1996-2000). The data sample has an integrated luminosity of 660 pb^-1 and was collected over a range of centre-of-mass energies from 161 to 209 GeV. Results are obtained by applying the method of direct reconstruction of the mass of the W from its decay products in both the W+W- -> lvqq and W+W- -> qqqq channels. The W mass result for the combined data set is M_W = 80.336 +/- 0.055 (Stat.) +/- 0.028 (Syst.) +/- 0.025 (FSI) +/- 0.009 (LEP) GeV/c^2, where FSI represents the uncertainty due to final state interaction effects in the qqqq channel, and LEP represents that arising from the knowledge of the collision energy of the accelerator. The combined value for the W width is Gamma_W = 2.404 +/- 0.140 (Stat.) +/- 0.077 (Syst.) +/- 0.065 (FSI) GeV/c^2. These results supersede all values previously published by the DELPHI collaboration. This paper is dedicated to the memory of Carlo Caso.A measurement of the W boson mass and width has been performed by the DELPHI collaboration using the data collected during the full LEP2 programme (1996-2000). The data sample has an integrated luminosity of 660 pb^-1 and was collected over a range of centre-of-mass energies from 161 to 209 GeV. Results are obtained by applying the method of direct reconstruction of the mass of the W from its decay products in both the W+W- -> lvqq and W+W- -> qqqq channels. The W mass result for the combined data set is M_W = 80.336 +/- 0.055 (Stat.) +/- 0.028 (Syst.) +/- 0.025 (FSI) +/- 0.009 (LEP) GeV/c^2, where FSI represents the uncertainty due to final state interaction effects in the qqqq channel, and LEP represents that arising from the knowledge of the collision energy of the accelerator. The combined value for the W width is Gamma_W = 2.404 +/- 0.140 (Stat.) +/- 0.077 (Syst.) +/- 0.065 (FSI) GeV/c^2. These results supersede all values previously published by the DELPHI collaboration. This paper is dedicated to the memory of Carlo Caso